Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals

FEMS Immunology and Medical Microbiology

Volumn 45, Issue 2, 2005, Pages 129-136

  Spear, Gregory T ^a   Alves, Mario E A F ^b   Cohen, Mardge H ^c   Bremer, James ^a   Landay, Alan L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Jr Hospital of Cook County   (United States)

Author keywords

Cytokine; HIV 1 RNA; Plasma; Saliva

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VIRUS RNA;

ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MOUTH INFLAMMATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SALIVA ANALYSIS; T LYMPHOCYTE;

CD4 LYMPHOCYTE COUNT; CYTOKINES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, VIRAL; SALIVA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 22844434853     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2005.03.002     Document Type: Article

References (33)

1. D.W. Archibald, and G.A. Cole In vitro inhibition of HIV-1 infectivity by human salivas AIDS Res. Hum. Retroviruses 6 1990 1425 1432
2. P.C. Fox, and B.J. Baum Isolation of HTLV-III virus from saliva in AIDS N. Engl. J. Med. 314 1986 1387
3. P.C. Fox, A. Wolff, C.K. Yeh, J.C. Atkinson, and B.J. Baum Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women, and children J. Am. Dent. Assoc. 118 1989 709 711
4. T.B. McNeely, M. Dealy, D.J. Dripps, J.M. Orenstein, S.P. Eisenberg, and S.M. Wahl Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro J. Clin. Invest. 96 1995 456 464
5. D.C. Shugars Endogenous mucosal antiviral factors of the oral cavity J. Infect. Dis. 179 Suppl 3 1999 S431 S435
6. D.C. Shugars, S.P. Sweet, D. Malamud, S.H. Kazmi, K. Page-Shafer, and S.J. Challacombe Saliva and inhibition of HIV-1 infection: molecular mechanisms Oral. Dis. 8 Suppl 2 2002 169 175
7. M.S. Cohen, D.C. Shugars, and S.A. Fiscus Limits on oral transmission of HIV-1 Lancet 356 2000 272
8. R.N. Shepard, J. Schock, K. Robertson, D.C. Shugars, J. Dyer, P. Vernazza, C. Hall, M.S. Cohen, and S.A. Fiscus Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments J. Clin. Microbiol. 38 2000 1414 1418
9. C.D. Pilcher, D.C. Shugars, S.A. Fiscus, W.C. Miller, P. Menezes, J. Giner, B. Dean, K. Robertson, C.E. Hart, J.L. Lennox, J.J. Eron Jr, and C.B. Hicks HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health Aids 15 2001 837 845
10. G. Liuzzi, A. Chirianni, M. Clementi, M. Zaccarelli, A. Antinori, and M. Piazza Reduction of HIV-1 viral load in saliva by indinavir-containing antiretroviral regimen Aids 16 2002 503 504
11. D.C. Shugars, L.L. Patton, S.A. Freel, L.R. Gray, R.T. Vollmer, J.J. Eron Jr, and S.A. Fiscus Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva J. Dent. Res. 80 2001 414 420
12. A.K. Iversen, L. Fugger, J. Eugen-Olsen, U. Balslev, T. Jensen, S. Wahl, J. Gerstoft, J.I. Mullins, and P. Skinhoj Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion J. Infect. Dis. 178 1998 1334 1342
13. S.B. Mostad, S. Jackson, J. Overbaugh, M. Reilly, B. Chohan, K. Mandaliya, P. Nyange, J. Ndinya-Achola, J.J. Bwayo, and J.K. Kreiss Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle J. Infect. Dis. 178 1998 983 991
14. T.C. Wright Jr, S. Subbarao, T.V. Ellerbrock, J.L. Lennox, T. Evans-Strickfaden, D.G. Smith, and C.E. Hart Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration Am. J. Obstet. Gynecol. 184 2001 279 285
15. C.E. Hart, J.L. Lennox, M. Pratt-Palmore, T.C. Wright, R.F. Schinazi, T. Evans-Strickfaden, T.J. Bush, C. Schnell, L.J. Conley, K.A. Clancy, and T.V. Ellerbrock Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract J. Infect. Dis. 179 1999 871 882
16. S.D. Lawn, S. Subbarao, T.C. Wright Jr, T. Evans-Strickfaden, T.V. Ellerbrock, J.L. Lennox, S.T. Butera, and C.E. Hart Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix J. Infect. Dis. 181 2000 1950 1956
17. P.S. Reichelderfer, R.W. Coombs, D.J. Wright, J. Cohn, D.N. Burns, S. Cu-Uvin, P.A. Baron, M.H. Coheng, A.L. Landay, S.K. Beckner, S.R. Lewis, and A.A. Kovacs Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract WHS 001 Study Team. Aids 14 2000 2101 2107
18. D.M. Money, Y.Y. Arikan, V. Remple, C. Sherlock, K. Craib, P. Birch, and D.R. Burdge Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus Am. J. Obstet. Gynecol. 188 2003 122 128
19. S. Cu-Uvin, A.M. Caliendo, S. Reinert, A. Chang, C. Juliano-Remollino, T.P. Flanigan, K.H. Mayer, and C.C. Carpenter Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA Aids 14 2000 415 421
20. G. Poli, A.L. Kinter, E. Vicenzi, and A.S. Fauci Cytokine regulation of acute and chronic HIV infection in vitro: from cell lines to primary mononuclear cells Res. Immunol. 145 1994 578 582
21. K.P. Black, K.W. Merrill, S. Jackson, and J. Katz Cytokine profiles in parotid saliva from HIV-1-infected individuals: changes associated with opportunistic infections in the oral cavity Oral Microbiol. Immunol. 15 2000 74 81
22. J.E. Leigh, C. Steele, F.L. Wormley Jr, W. Luo, R.A. Clark, W. Gallaher, and P.L. Fidel Jr Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 1998 373 380
23. J. Slavinsky 3rd, T. Myers, R.K. Swoboda, J.E. Leigh, S. Hager, and P.L. Fidel Jr Th1/Th2 cytokine profiles in saliva of HIV-positive smokers with oropharyngeal candidiasis Oral Microbiol. Immunol. 17 2002 38 43
24. L. Al-Harthi, D.J. Wright, D. Anderson, M. Cohen, D. Matity Ahu, J. Cohn, S. Cu-Unvin, D. Burns, P. Reichelderfer, S. Lewis, S. Beckner, A. Kovacs, and A. Landay The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments J. Interferon. Cytokine Res. 20 2000 719 724
25. R. Boom, C.J. Sol, M.M. Salimans, C.L. Jansen, P.M. Wertheim-van Dillen, and J. van der Noordaa Rapid and simple method for purification of nucleic acids J. Clin. Microbiol. 28 1990 495 503
26. M. Saves, P. Morlat, G. Chene, E. Peuchant, I. Pellegrin, F. Bonnet, N. Bernard, D. Lacoste, R. Salamon, and J. Beylot Prognostic value of plasma markers of immune activation in patients with advanced HIV disease treated by combination antiretroviral therapy Clin. Immunol. 99 2001 347 352
27. N. Aziz, P. Nishanian, J.M. Taylor, R.T. Mitsuyasu, J.M. Jacobson, B.J. Dezube, M.M. Lederman, R. Detels, and J.L. Fahey Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection J. Infect. Dis. 179 1999 843 848
28. N. Aziz, P. Nishanian, R. Mitsuyasu, R. Detels, and J.L. Fahey Variables that affect assays for plasma cytokines and soluble activation markers Clin. Diagn. Lab Immunol. 6 1999 89 95
29. M.S. Sulkowski, R.E. Chaisson, C.L. Karp, R.D. Moore, J.B. Margolick, and T.C. Quinn The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults J. Infect. Dis. 178 1998 1642 1648
30. G.P. Rizzardi, W. Barcellini, G. Tambussi, F. Lillo, M. Malnati, L. Perrin, and A. Lazzarin Plasma levels of soluble CD30, tumour necrosis factor (TNF)-α and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome Aids 10 1996 F45 F50
31. N.P. Walsh, J.C. Montague, N. Callow, and A.V. Rowlands Saliva flow rate, total protein concentration and osmolality as potential markers of whole body hydration status during progressive acute dehydration in humans Arch. Oral Biol. 49 2004 149 154
32. T.O. Narhi, J. Tenovuo, A. Ainamo, and P. Vilja Antimicrobial factors, sialic acid, and protein concentration in whole saliva of the elderly Scand. J. Dent. Res. 102 1994 120 125
33. K. Page-Shafer, C.H. Shiboski, D.H. Osmond, J. Dilley, W. McFarland, S.C. Shiboski, J.D. Klausner, J. Balls, D. Greenspan, and J.S. Greenspan Risk of HIV infection attributable to oral sex among men who have sex with men and in the population of men who have sex with men Aids 16 2002 2350 2352